Protalix Biotherapeutics Inc
PLX1.485USD
+0.035+2.41%
交易中 （美東）報價延遲15分鐘
116.03M總市值
29.69本益比TTM
關於 Protalix Biotherapeutics Inc 公司
Protalix BioTherapeutics, Inc. 是一家生物製藥公司。該公司專注於通過其專有的植物細胞表達系統 ProCellEx 表達重組治療蛋白的開發和商業化。此外，該公司正在開發用於治療嚴重痛風的聚乙二醇化尿酸酶或 PRX-115、用於治療 NET 相關疾病的長效 (LA) DNase I 或 PRX-119，以及其他技術和臨牀前資產。其產品 Elelyso 是一種用於治療戈謝病患者的酶替代療法 (ERT)。其 ProCellEx 平臺用於製造其已獲批和上市的產品以及 PRX-115 和 PRX-119。PRX-115 是一種植物細胞表達的重組聚乙二醇化尿酸酶（尿酸氧化酶），這是一種正在開發的化學修飾酶，可用於治療嚴重痛風。 PRX-119 是一種植物細胞表達的聚乙二醇化重組人 DNase I 候選產品。
公司簡介
公司代碼PLX
公司名稱Protalix Biotherapeutics Inc
上市日期Sep 06, 2010
CEOMr. Dror Bashan
員工數量207
證券類型Ordinary Share
年結日Sep 06
公司地址2 University Plaza
城市HACKENSACK
上市交易所Euronext Paris
國家United States of America
郵編07601
電話12016969345
網址https://protalix.com/
公司代碼PLX
上市日期Sep 06, 2010
CEOMr. Dror Bashan
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Dror Bashan
Mr. Dror Bashan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.28M
--
Mr. Eyal Rubin
Mr. Eyal Rubin
Chief Financial Officer, Senior Vice President, Treasurer, Secretary
Chief Financial Officer, Senior Vice President, Treasurer, Secretary
660.91K
+15.95%
Mr. Yaron Naos
Mr. Yaron Naos
Senior Vice President - Operations
Senior Vice President - Operations
207.30K
--
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Independent Director
Independent Director
174.00K
--
Ms. Gwen A. Melincoff
Ms. Gwen A. Melincoff
Independent Director
Independent Director
40.00
--
Dr. Pol F. Boudes, M.D.
Dr. Pol F. Boudes, M.D.
Independent Director
Independent Director
40.00
--
Mr. Mike Moyer
Mr. Mike Moyer
Investor Relations
Investor Relations
--
--
Mr. Amos Bar Shalev
Mr. Amos Bar Shalev
Independent Director
Independent Director
--
--
Dr. Shmuel (Muli) Ben-Zvi, Ph.D.
Dr. Shmuel (Muli) Ben-Zvi, Ph.D.
Independent Director
Independent Director
--
--
Dr. Eliot Richard Forster, Ph.D.
Dr. Eliot Richard Forster, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Dror Bashan
Mr. Dror Bashan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.28M
--
Mr. Eyal Rubin
Mr. Eyal Rubin
Chief Financial Officer, Senior Vice President, Treasurer, Secretary
Chief Financial Officer, Senior Vice President, Treasurer, Secretary
660.91K
+15.95%
Mr. Yaron Naos
Mr. Yaron Naos
Senior Vice President - Operations
Senior Vice President - Operations
207.30K
--
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Independent Director
Independent Director
174.00K
--
Ms. Gwen A. Melincoff
Ms. Gwen A. Melincoff
Independent Director
Independent Director
40.00
--
Dr. Pol F. Boudes, M.D.
Dr. Pol F. Boudes, M.D.
Independent Director
Independent Director
40.00
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 7月23日 週三
更新時間: 7月23日 週三
持股股東
股東類型
持股股東
持股股東
佔比
HIR Investments Ltd
5.92%
Bashan (Dror)
2.87%
Renaissance Technologies LLC
1.49%
Millennium Management LLC
1.21%
Susquehanna International Group, LLP
1.08%
Other
87.43%
持股股東
持股股東
佔比
HIR Investments Ltd
5.92%
Bashan (Dror)
2.87%
Renaissance Technologies LLC
1.49%
Millennium Management LLC
1.21%
Susquehanna International Group, LLP
1.08%
Other
87.43%
股東類型
持股股東
佔比
Corporation
6.22%
Investment Advisor
4.67%
Individual Investor
4.18%
Hedge Fund
3.67%
Investment Advisor/Hedge Fund
2.30%
Research Firm
0.82%
Pension Fund
0.26%
Venture Capital
0.05%
Other
77.84%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
182
17.64M
22.16%
+1.73M
2025Q1
182
19.45M
25.30%
+4.26M
2024Q4
169
15.65M
21.26%
-1.03M
2024Q3
162
14.11M
19.17%
-5.41M
2024Q2
163
16.36M
22.25%
-4.44M
2024Q1
143
16.45M
23.43%
-4.40M
2023Q4
145
17.20M
24.67%
-3.21M
2023Q3
142
16.45M
24.08%
-6.46M
2023Q2
132
16.38M
24.76%
-4.13M
2023Q1
95
13.57M
27.32%
-11.07M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
HIR Investments Ltd
4.71M
5.92%
--
--
Apr 30, 2025
Bashan (Dror)
2.28M
2.87%
--
--
Apr 30, 2025
Renaissance Technologies LLC
1.19M
1.49%
+70.95K
+6.35%
Mar 31, 2025
Millennium Management LLC
963.01K
1.21%
+575.09K
+148.25%
Mar 31, 2025
Susquehanna International Group, LLP
858.65K
1.08%
+858.65K
--
Mar 31, 2025
Northern Trust Global Investments Limited
683.30K
0.86%
-46.98K
-6.43%
Mar 31, 2025
Rubin (Eyal)
660.91K
0.83%
+90.91K
+15.95%
Apr 30, 2025
Marshall Wace LLP
615.09K
0.77%
+513.19K
+503.62%
Mar 31, 2025
Connor, Clark & Lunn Investment Management Ltd.
482.88K
0.61%
+482.88K
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Franklin US Small Cap Multifactor Index ETF
0.01%
DFA Dimensional US Sustainability Core 1 ETF
0%
Proshares Ultra Russell 2000
0%
Global X Russell 2000 ETF
0%
iShares Russell 2000 Value ETF
0%
Avantis International Small Cap Equity ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
查看更多
iShares Micro-Cap ETF
佔比0.02%
iShares Russell 2000 Growth ETF
佔比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.01%
Franklin US Small Cap Multifactor Index ETF
佔比0.01%
DFA Dimensional US Sustainability Core 1 ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
Global X Russell 2000 ETF
佔比0%
iShares Russell 2000 Value ETF
佔比0%
Avantis International Small Cap Equity ETF
佔比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
